Zoetis Inc. (ZOE.DE)

EUR 138.68

(1.2%)

EBITDA Summary of Zoetis Inc.

  • Zoetis Inc.'s latest annual EBITDA in 2023 was 3.66 Billion USD , up 21.82% from previous year.
  • Zoetis Inc.'s latest quarterly EBITDA in 2024 Q2 was 1.05 Billion USD , up 11.43% from previous quarter.
  • Zoetis Inc. reported an annual EBITDA of 3.34 Billion USD in 2022, up 4.18% from previous year.
  • Zoetis Inc. reported an annual EBITDA of 3.16 Billion USD in 2021, up 6.85% from previous year.
  • Zoetis Inc. reported a quarterly EBITDA of 1.05 Billion USD for 2024 Q2, up 11.43% from previous quarter.
  • Zoetis Inc. reported a quarterly EBITDA of N/A for 2023 FY, up 21.82% from previous quarter.

Annual EBITDA Chart of Zoetis Inc. (2023 - 2009)

Historical Annual EBITDA of Zoetis Inc. (2023 - 2009)

Year EBITDA EBITDA Growth
2023 3.66 Billion USD 21.82%
2022 3.34 Billion USD 4.18%
2021 3.16 Billion USD 6.85%
2020 2.66 Billion USD 22.38%
2019 2.43 Billion USD 7.16%
2018 2.08 Billion USD 14.97%
2017 1.94 Billion USD 21.97%
2016 1.63 Billion USD 41.33%
2015 1.05 Billion USD 2.74%
2014 1.14 Billion USD 14.96%
2013 1.01 Billion USD -16.29%
2012 1.06 Billion USD 23.78%
2011 858 Million USD 72.29%
2010 498 Million USD 44.35%
2009 345 Million USD 0.0%

Peer EBITDA Comparison of Zoetis Inc.

Name EBITDA EBITDA Difference
MPH Health Care AG 33.31 Million EUR -10904.394%
Apontis Pharma AG -12.94 Million EUR 28427.844%
Dermapharm Holding SE 277.29 Million EUR -1222.053%
Evotec SE 7.82 Million EUR -46761.818%
MERCK Kommanditgesellschaft auf Aktien 5.52 Billion EUR 33.599%
PharmaSGP Holding SE 35.86 Million EUR -10120.81%
SynBiotic SE -7.12 Million EUR 51569.976%